Showing 2321-2330 of 2751 results for "".
- Sculptra Scores FDA Nod for Cheek Wrinkleshttps://modernaesthetics.com/news/sculptra-scores-fda-nod-for-cheeks/2473402/The U.S. Food and Drug Administration (FDA) has approved Sculptra (injectable poly-L-lactic acid (PLLA-SCA)) for the correction of fine lines and wrinkles in the cheek area. Sculptra is the first FDA-approved PLLA collagen stimulator that helps stimulate natural collagen produ
- Study: “Stuck” Stem Cells Turn Hair Grayhttps://modernaesthetics.com/news/study-stuck-stem-cells-turn-hair-gray/2473396/Certain stem cells move between growth compartments in hair follicles, but they can get stuck as people age and lose their ability to mature and maintain hair color, a new study shows. The new work focused on cells in the skin of mice and also found in humans called melanocyt
- Filler Fatigue: Galderma Survey Separates Fact from Fictionhttps://modernaesthetics.com/news/filler-fatigue-galderma-survey-separates-fact-from-fiction/2473395/Forty percent of people say they would discourage others from using facial injectables to reduce wrinkles or provide volume, and 34% said they believed the results of such treatments look fake and unnatural, according to a new poll sponsored by Galderma. Despite these views, the same re
- New from BTL: Meet EXIONhttps://modernaesthetics.com/news/new-from-btl-meet-exion/2473392/Just in time for their 30th anniversary, BTL is launching EXION, a multiplatform device featuring micro-needling RF, a non-invasive face and body applicator for skin laxity, and the EMFEMME 360 applicator for intimate health. EXION can also be combined with EMFACE to treat bot
- Establishment Labs Surpasses 3 Million Motiva Deviceshttps://modernaesthetics.com/news/establishment-labs-surpasses-3-million-motiva-devices/2473383/Establishment Labs Holdings announced that it has surpassed 3 million Motiva devices in market. The devices have been delivered to plastic and reconstructive surgeons since 2010 and are available in more than 85 countries. “Since its founding, Establishment Labs has been guid
- Cutera Unveils Updated truBody Brandhttps://modernaesthetics.com/news/cutera-unveils-updated-trubody-brand/2473378/Cutera has launched an updated truBody brand that pairs two technologies designed to create a customized, convenient, and complete approach to fat reduction and muscle toning with 15-minute treatment options, according to a company news release. The new truBody brand elevates both pract
- The Cellulite Wars Heat Up: Sentient Sculpt Enters U.S. Markethttps://modernaesthetics.com/news/the-cellulite-wars-heat-up-sentient-sculpt-enters-us-market/2473377/Sentient, LLC is bringing Sentient Sculpt to the U.S. market. Sentient Sculpt is a non-invasive professional electromagnetic wave and microwave treatment for cellulite reduction. Unlike other products on the market that are absorbed in the skin or medical devices that incise tissue, Sen
- Botox Cosmetic, IFundWomen Join Forces to Help Close the Confidence Gap for Women Entrepreneurshttps://modernaesthetics.com/news/botox-cosmetic-ifundwomen-join-forces-to-help-close-the-confidence-gap-for-women-entrepreneurs/2473375/In honor of International Women's Day, Allergan Aesthetics,’ an AbbVie company, is partnering with IFundWomen, the funding marketplace for women-owned businesses, on a grant program. Women entrepreneurs can apply for the opportunity to receive one of 20 grants worth
- BTL Cracks Down on Counterfeit Devices in the U.S.https://modernaesthetics.com/news/btl-cracks-down-on-counterfeit-devices-in-the-us/2473373/BTL is making inroads in its efforts to safeguard medical providers and consumers from counterfeit devices in the United States through legal action and the seizure of illegally imported devices at the border. BTL has filed court documents stating that defendants use and sell knock
- U.S. FDA Clears Renuvion to Coagulate and Contract Soft Tissues, Including Subcutaneous Tissuehttps://modernaesthetics.com/news/fda-clears-of-renuvion-to-coagulate-and-contract-soft-tissues-including-subcutaneous-tissue/2473371/The U.S. Food and Drug Administration (FDA) has cleared the use of the Renuvion APR Handpiece for the delivery of radiofrequency energy and/or helium plasma where coagulation/contraction of soft tissue is needed. (Soft tissue includes subcutaneous tissue.) “We are pleas